BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18020451)

  • 1. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins.
    Schlievert PM; Case LC; Nemeth KA; Davis CC; Sun Y; Qin W; Wang F; Brosnahan AJ; Mleziva JA; Peterson ML; Jones BE
    Biochemistry; 2007 Dec; 46(50):14349-58. PubMed ID: 18020451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production.
    Schlievert PM; Kilgore SH; Beck LA; Yoshida T; Klingelhutz AJ; Leung DYM
    mSphere; 2023 Feb; 8(1):e0057622. PubMed ID: 36598227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis.
    Merriman JA; Nemeth KA; Schlievert PM
    PLoS One; 2014; 9(4):e95661. PubMed ID: 24748386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
    Katahira EJ; Davidson SM; Stevens DL; Bolz DD
    J Med Microbiol; 2019 Feb; 68(2):255-262. PubMed ID: 30556803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo.
    Lin YC; Schlievert PM; Anderson MJ; Fair CL; Schaefers MM; Muthyala R; Peterson ML
    PLoS One; 2009 Oct; 4(10):e7499. PubMed ID: 19838303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
    Strandberg KL; Peterson ML; Schaefers MM; Case LC; Pack MC; Chase DJ; Schlievert PM
    Clin Infect Dis; 2009 Dec; 49(11):1711-7. PubMed ID: 19863450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of totarol on exotoxin proteins hemolysin and enterotoxins secreted by Staphylococcus aureus.
    Shi C; Zhao X; Li W; Meng R; Liu Z; Liu M; Guo N; Yu L
    World J Microbiol Biotechnol; 2015 Oct; 31(10):1565-73. PubMed ID: 26193949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, epidemiology, antimicrobial resistance, and exotoxin genes (including that of Panton-Valentine leukocidin) of gentamicin-susceptible methicillin-resistant Staphylococcus aureus (GS-MRSA) isolated at a paediatric teaching hospital in New South Wales, Australia.
    Gubbay JB; Gosbell IB; Barbagiannakos T; Vickery AM; Mercer JL; Watson M
    Pathology; 2008 Jan; 40(1):64-71. PubMed ID: 18038318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PURIFICATION OF STAPHYLOCOCCAL BETA-HEMOLYSIN AND ITS ACTION ON STAPHYLOCOCCAL AND STREPTOCOCCAL CELL WALLS.
    CHESBRO WR; HEYDRICK FP; MARTINEAU R; PERKINS GN
    J Bacteriol; 1965 Feb; 89(2):378-89. PubMed ID: 14255704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.
    Hamilton SM; Bryant AE; Carroll KC; Lockary V; Ma Y; McIndoo E; Miller LG; Perdreau-Remington F; Pullman J; Risi GF; Salmi DB; Stevens DL
    Clin Infect Dis; 2007 Dec; 45(12):1550-8. PubMed ID: 18190315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purpura fulminans due to Staphylococcus aureus.
    Kravitz GR; Dries DJ; Peterson ML; Schlievert PM
    Clin Infect Dis; 2005 Apr; 40(7):941-7. PubMed ID: 15824983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus.
    Stevens DL; Ma Y; Salmi DB; McIndoo E; Wallace RJ; Bryant AE
    J Infect Dis; 2007 Jan; 195(2):202-11. PubMed ID: 17191165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Leung DY; Meissner HC; Fulton DR; Murray DL; Kotzin BL; Schlievert PM
    Lancet; 1993 Dec; 342(8884):1385-8. PubMed ID: 7901681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SaeRS Two-Component System Is a Direct and Dominant Transcriptional Activator of Toxic Shock Syndrome Toxin 1 in Staphylococcus aureus.
    Baroja ML; Herfst CA; Kasper KJ; Xu SX; Gillett DA; Li J; Reid G; McCormick JK
    J Bacteriol; 2016 Oct; 198(19):2732-42. PubMed ID: 27457715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.
    Shumba P; Mairpady Shambat S; Siemens N
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolysins augment superantigen penetration of stratified mucosa.
    Brosnahan AJ; Mantz MJ; Squier CA; Peterson ML; Schlievert PM
    J Immunol; 2009 Feb; 182(4):2364-73. PubMed ID: 19201891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling staphylococcal pneumonia in a human 3D lung tissue model system delineates toxin-mediated pathology.
    Mairpady Shambat S; Chen P; Nguyen Hoang AT; Bergsten H; Vandenesch F; Siemens N; Lina G; Monk IR; Foster TJ; Arakere G; Svensson M; Norrby-Teglund A
    Dis Model Mech; 2015 Nov; 8(11):1413-25. PubMed ID: 26398950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus t034.
    Welinder-Olsson C; Florén-Johansson K; Larsson L; Oberg S; Karlsson L; Ahrén C
    Emerg Infect Dis; 2008 Aug; 14(8):1271-2. PubMed ID: 18680653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources.
    Bonventre PF; Weckbach L; Staneck J; Schlievert PM; Thompson M
    Infect Immun; 1983 Jun; 40(3):1023-9. PubMed ID: 6189784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.